Why Invest in the Southeast? In sum, because the region’s dynamic and growing economy produces strong deal flow at reasonable valuations, and has historically produced higher returns for venture investors than other regions of the country. The Southeastern economy...Read More
Make 2015 the year for your company to stand out. The deadline for the BIO/Plan has been extended to May 15th!! Don’t hesitate, more information available here: Southeast BIO website.
Spyryx Biosciences, Inc., a company developing novel therapeutics for respiratory diseases, including cystic fibrosis (CF) and COPD, announced today that it has secured $18 million in Series A venture capital financing.
Please join us in beautiful Charleston, S.C. next November for the 17th Annual SEBIO Investor & Partnering Forum!
More details to come in early 2015